Key Points
- Stabilize ABCs; treat life‑threatening derangements immediately.
- Confirm diagnosis early with highest‑yield imaging/labs.
- Initiate guideline‑based therapy and escalate by response.
- Plan disposition and follow‑up explicitly.
Clinical Synopsis & Reasoning
HHS presents with profound hyperglycemia, hyperosmolality (>320 mOsm/kg), and minimal ketosis. Initial 0.9% saline restores volume; transition to 0.45% saline guided by corrected sodium and osmolality. Start regular insulin 0.05–0.1 U/kg/h only after initial fluids; avoid rapid osmolality shifts. Replace potassium to maintain 4.0–5.0 mEq/L; add dextrose when glucose <300 mg/dL.
Treatment Strategy & Disposition
HHS presents with profound hyperglycemia, hyperosmolality (>320 mOsm/kg), and minimal ketosis. Initial 0.9% saline restores volume; transition to 0.45% saline guided by corrected sodium and osmolality. Start regular insulin 0.05–0.1 U/kg/h only after initial fluids; avoid rapid osmolality shifts. Replace potassium to maintain 4.0–5.0 mEq/L; add dextrose when glucose <300 mg/dL.
Epidemiology / Risk Factors
- Risk varies by comorbidity and precipitating factors
Initial Targets
| Parameter | Target/Action |
|---|---|
| Hemodynamics | Maintain perfusion; avoid hypotension |
| Monitoring | Serial exam, labs, and imaging |
| Therapy | Start early, reassess, de‑escalate when appropriate |
Investigations
| Test | Role / Rationale | Typical Findings | Notes |
|---|---|---|---|
| CBC | Screen leukocytosis/anemia | Context‑specific | Trend response |
| BMP | Electrolytes/renal function | Derangements common | Replace K+/Mg2+ |
| Key imaging | Condition‑specific (CTA/MRI/Endoscopy) | See text | Do not delay when red flags |
Pharmacology
| Medication | Mechanism | Onset | Role in Therapy | Limitations |
|---|---|---|---|---|
| 0.9% Saline then 0.45% | Crystalloid | Immediate | Restore volume/correct osmolality | Switch to D5 when glucose <300 |
| Regular insulin infusion | Insulin | Minutes | Lower glucose/osmolality | Start after fluids; 0.05–0.1 U/kg/h |
| Potassium chloride | Electrolyte | Immediate | Prevent arrhythmia | Replace to 4–5 mEq/L |
Prognosis / Complications
- Outcome depends on timeliness of diagnosis and definitive therapy
Patient Education / Counseling
- Explain red flags, adherence, and follow‑up plan
References
- ADA/Consensus Report on Hyperglycemic Crises (2024) — Link
- Cleveland Clinic J Med summary (2025) — Link
Use the Library, QBank, CCS, and analytics in one study workflow.
You just reviewed Hyperosmolar Hyperglycemic State — Fluid Strategy, Insulin, and Electrolyte Targets. MDSteps helps you turn that review into exam-style practice, missed-item flashcards, and a readiness dashboard that shows what to study next.
- 16,000+ USMLE-style questions across Step 1, Step 2, and Step 3
- CCS simulator with timed orders, live vitals, and case feedback
- Depth-on-Demand™ explanations and Anki-exportable flashcards
- Library + QBank + analytics for $27/month or $299 lifetime